Reducing the Risk of Endophthalmitis Following Intravitreal Injections
- 1 January 2007
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Retina
- Vol. 27 (1), 10-12
- https://doi.org/10.1097/iae.0b013e3180307271
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Use of Intravitreal Ganciclovir (Dihydroxy Propoxymethyl Guanine) for Cytomegalovirus Retinitis in a Patient With AIDSAmerican Journal of Ophthalmology, 1987
- Experimental Aspects and Their Clinical ApplicationOphthalmology, 1978
- Further Observations on the Diagnosis, Cause, and Treatment of EndophthalmitisAmerican Journal of Ophthalmology, 1976
- The Use of Liquid Silicone in Retinal Detachment SurgeryAmerican Journal of Ophthalmology, 1962
- TREATMENT OF LATE POSTOPERATIVE INTRAOCULAR INFECTIONS WITH INTRAOCULAR INJECTION OF PENICILLINAmerican Journal of Ophthalmology, 1947
- PENICILLIN AND THE CONTROL OF DEEP INTRA-OCULAR INFECTIONBritish Journal of Ophthalmology, 1945
- Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzung von Luft in den GlaskörperAlbrecht von Graefes Archiv für Ophthalmologie, 1911